Ascletis Announces Poster Presentations on the Study Results of ASC30 and ASC47 at the 85th Scientific Sessions of American Diabetes Association (ADA) ...Middle East

HONG KONG, June 8, 2025 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that poster presentations on preliminary studies of its oral small molecule GLP-1 Receptor (GLP-1R) agonist ASC30 and adipose-targeted, muscle-preserving weight loss drug candidate ASC47 will...

Read More Details
Finally We wish PressBee provided you with enough information of ( Ascletis Announces Poster Presentations on the Study Results of ASC30 and ASC47 at the 85th Scientific Sessions of American Diabetes Association (ADA) )

Also on site :

• Rock Legend Shares Bold Message About L.A. Protests
• ‘Mormon Wives’ Star Taylor Frankie Paul Posts About ‘Betrayal’ Ahead of Season 2, Part 2 Drop
• AriZona's 'Perfect' New Flavor Sends Fans Racing to the Store